Company Overview
Zogenix Europe Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Monday 07 June 2010, so this is a well established company. Zogenix Europe Limited has been in business for 15 years and 9 months. The accounts status is small and the accounts are next due on Wednesday 30 September 2026.
Registered Address

208 Bath Road, Slough, Berkshire, SL1 3WE
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameZOGENIX EUROPE LIMITED
Company Number07275920
Registered Office Address208 Bath Road
 SL1 3WE
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date07/06/2010
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategorySMALL
Returns Next Due Date05/07/2017
Returns Last Made Up Date07/06/2016
Directors & Members
Show Resigned
Yogesh Khatri - Director
(British, 61 years old, born October 1965)
Appointed 14 April 2022
 Active
Nico Reynders - Director
(Belgian, 54 years old, born August 1972)
Appointed 01 December 2024
 Active
Secretaries
Show Resigned
Other Company Directorships
Yogesh Khatri
CELLTECH GROUP LIMITED
CELLTECH JAPAN LIMITED
CELLTECH LIMITED
CELLTECH PENSION TRUSTEES LIMITED
CELLTECH PHARMA EUROPE LIMITED
CELLTECH R&D LIMITED
CHIROSCIENCE GROUP LIMITED
CHIROSCIENCE R&D LIMITED
CONFIRMANT LIMITED
DARWIN DISCOVERY LIMITED
EVANS HEALTHCARE LIMITED
FIPAR
FIPAR UK LIMITED
INTERNATIONAL MEDICATION SYSTEMS (U.K.) LIMITED
KAPURE LTD
MEDEVA INTERNATIONAL LIMITED
MEDEVA LIMITED
MEDEVA UK PENSION LIMITED
OXFORD GLYCOSCIENCES
OXFORD GLYCOSCIENCES (UK) LIMITED
SCHWARZ PHARMA LIMITED
UCB (INVESTMENTS) LIMITED
UCB BRIDGWATER PENSION TRUST LIMITED
UCB BRITISH PENSION TRUST LIMITED
UCB FIPAR LIMITED
UCB IRELAND
UCB PHARMA LIMITED
UCB WATFORD LIMITED
VIKING TRADING CO. LIMITED
ZOGENIX INTERNATIONAL LIMITED
Nico Reynders
CELLTECH GROUP LIMITED
CELLTECH R&D LIMITED
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY
UCB (INVESTMENTS) LIMITED
UCB PHARMA LIMITED
ZOGENIX INTERNATIONAL LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2019 31-Dec-2018
Balance Sheet
Fixed Assets 28,677,647 28,677,647 28,677,647
Current Assets 166,073 166,073 166,373
Creditors Due Within One Year 24,446,223 24,446,223 24,446,224
Working Cap -24,280,150 -24,280,150 -24,279,851
Total Assets Less Current Liabilities 4,397,497 4,397,497 4,397,796
Long-term Liabilities 3,652,477 3,652,477 3,652,477
Net Assets 745,020 745,020 745,319
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 745,020 745,020 745,319
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2019 31-Dec-2018
Tangible Fixed Assets - - -
Fixed Assets 99.4% 99.4% 99.4%
Stocks Inventory - - -
Debtors - - -
Cash Bank In Hand 0.6% 0.6% 0.6%
Current Assets 0.6% 0.6% 0.6%
Creditors Due Within One Year 84.8% 84.8% 84.8%
Net Current Assets Liabilities -84.2% -84.2% -84.2%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 2.6% 2.6% 2.6%
Capital Employed - - -
Total Assets Less Current Liabilities 15.2% 15.2% 15.2%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2019 31-Dec-2018
Liquidity Ratio 0.0 0.0 0.0
Solvency Ratio 1.0 1.0 1.0
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 2
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 2
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2019 31-Dec-2018
Assets 28,843,720 28,843,720 28,844,020
Debt 28,098,700 28,098,700 28,098,701
Net Assets/Debt 745,020 745,020 745,319

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company as inferred by the balance sheet the amount of net assets represents a relatively small margin of cover over total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company as inferred by the balance sheet the amount of net assets represents a relatively small margin of cover over total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company as inferred by the balance sheet the amount of net assets represents a relatively small margin of cover over total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around SL1 3WE
UCB PHARMA LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
DARWIN DISCOVERY LIMITED
208 Bath Road, Slough, Berkshire, SL1 3WE
UCB (INVESTMENTS) LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
CELLTECH R&D LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
CELLTECH GROUP LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
UCB BRITISH PENSION TRUST LIMITED
208 Bath Road, Slough, SL1 3WE
CELLTECH PENSION TRUSTEES LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
Document Filings
Statement of capital on 14 January 2026
Statement by Directors
Solvency Statement dated 13/01/26
Resolutions
Confirmation statement made on 7 June 2025 with no updates
Appointment of Mr Nico Victor Reynders as a director on 1 December 2024
Confirmation statement made on 7 June 2024 with updates
Notification of Ucb Biosciences Inc. as a person with significant control on 1 April 2024
Cessation of Zogenix Inc as a person with significant control on 1 April 2024
Confirmation statement made on 7 June 2023 with updates
Register inspection address has been changed from 11th Floor Whitefriars Lewins Mead Bristol BS1 2NT England to 208 Bath Road Slough Berkshire SL1 3WE
Register(s) moved to registered office address 208 Bath Road Slough Berkshire SL1 3WE
Registered office address changed from 208 Bath Road Slough Berkshire SL1 3WE England to 208 Bath Road Slough Berkshire SL1 3WE on 25 January 2023
Registered office address changed from 208 208 Bath Road Slough Berkshire SL1 3WE England to 208 Bath Road Slough Berkshire SL1 3WE on 25 January 2023
Registered office address changed from Suite 2 First Floor 10 Temple Back Bristol BS1 6FL United Kingdom to 208 208 Bath Road Slough Berkshire SL1 3WE on 25 January 2023
Confirmation statement made on 7 June 2022 with no updates
Termination of appointment of Stephen James Farr as a director on 15 April 2022
Appointment of Mr Yogesh Khatri as a director on 14 April 2022
Registered office address changed from 11th Floor Whitefriars Lewins Mead Bristol BS1 2NT to Suite 2 First Floor 10 Temple Back Bristol BS1 6FL on 27 April 2022
Termination of appointment of Michael Patrick Smith as a director on 18 March 2022
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free